No Data
Lineage Cell Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Lineage Cell Therapeutics Price Target Raised to $9.00/Share From $7.00 by HC Wainwright & Co.
Express News | Lineage Cell Therapeutics Inc : H.c. Wainwright Raises Target Price to $9 From $7
Is Lineage Cell Therapeutics (LCTX) the Best New Pick in Brad Gerstner's Portfolio?
Insider Purchase: President and CEO of $LCTX (LCTX) Buys 40,000 Shares
Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
No Data
Jeff Boyd : Kind of a small purchase but the stock and option issuance might put a floor under the price. Took a small position yesterday.
Trytosaveabit OP Jeff Boyd : Yeah it’s not the biggest buy! But he did buy on the open market and with 13K+ of his own money! I’m sure he didn’t buy with the plans on losing money?? Hehehe! That tends to make me a bit more interested! GL and big profits to ya.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")